Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Medtronic
Baxter
Merck
Boehringer Ingelheim

Last Updated: August 13, 2022

Investigational Drug Information for SRX246


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug SRX246?

SRX246 is an investigational drug.

There have been 7 clinical trials for SRX246. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2016.

The most common disease conditions in clinical trials are Anxiety Disorders, Disease, and Stress Disorders, Post-Traumatic. The leading clinical trial sponsors are Azevan Pharmaceuticals, National Institute of Mental Health (NIMH), and National Institute of Neurological Disorders and Stroke (NINDS).

There is one US patent protecting this investigational drug and sixty-two international patents.

Recent Clinical Trials for SRX246
TitleSponsorPhase
Effects of SRX246 on an Experimental Model of Fear and Anxiety in HumansNational Institute of Mental Health (NIMH)Phase 1
Effects of SRX246 on an Experimental Model of Fear and Anxiety in HumansAzevan PharmaceuticalsPhase 1
Effects of SRX246 on an Experimental Model of Fear and Anxiety in HumansNational Institute of Mental Health (NIMH)Phase 1

See all SRX246 clinical trials

Clinical Trial Summary for SRX246

Top disease conditions for SRX246
Top clinical trial sponsors for SRX246

See all SRX246 clinical trials

International Patents for SRX246

Drugname Country Document Number Estimated Expiration Related US Patent
SRX246 Australia AU2011272738 2030-07-01 See Plans and Pricing
SRX246 Australia AU2015258200 2030-07-01 See Plans and Pricing
SRX246 Canada CA2804001 2030-07-01 See Plans and Pricing
SRX246 China CN103269584 2030-07-01 See Plans and Pricing
SRX246 China CN107007596 2030-07-01 See Plans and Pricing
SRX246 European Patent Office EP2587919 2030-07-01 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Medtronic
Baxter
Merck
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.